The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Antimicrobial Activity and Resistance: Influencing Factors
Open accessAbstract
Rational use of antibiotic is the key approach to improve the antibiotic performance and tackling of the antimicrobial resistance. The efficacy of antimicrobials are influenced by many factors: (1) bacterial status (susceptibility and resistance, tolerance, persistence, biofilm) and inoculum size; (2) antimicrobial concentrations [mutant selection window (MSW) and sub-inhibitory concentration]; (3) host factors (serum effect and impact on gut micro-biota). Additional understandings regarding the linkage between antimicrobial usages, bacterial status and host response offers us new insights and encourage the struggle for the designing of antimicrobial treatment regimens that reaching better clinical outcome and minimizing the emergence of resistance at the same time.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
Wiegand, I., Hilpert, K., & Hancock, R. E. W. (2008) · Nature Protocols · doi:10.1038/nprot.2007.521 · Cited by 6,156
Gut microbiota in health and disease
Sekirov, I., Russell, S. L., Antunes, L. C. M., & Finlay, B. B. (2010) · Physiological Reviews · doi:10.1152/physrev.00045.2009 · Cited by 4,182
Bacterial Persistence as a Phenotypic Switch
Balaban, N. Q., Merrin, J., Chait, R., Kowalik, L., & Leibler, S. (2004) · Science · doi:10.1126/science.1099390 · Cited by 2,952 · cited 2×
“Tolerance by lag phase occurs when the duration of the growth arrest is longer than the antibiotic treatment time (Balaban et al., 2004).”
BackgroundPersister cells, dormancy and infectious disease
Lewis, K. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1557 · Cited by 2,052
Cox, L. M., Yamanishi, S., Sohn, J., Alekseyenko, A. V., Leung, J. M., Cho, I., Kim, S. G., Li, H., Gao, Z., Mahana, D., et al. (2014) · Cell · doi:10.1016/j.cell.2014.05.052 · Cited by 1,859
Microbiological effects of sublethal levels of antibiotics
Andersson, D. I., & Hughes, D. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3270 · Cited by 1,757
Selection of Resistant Bacteria at Very Low Antibiotic Concentrations
Gullberg, E., Cao, S., Berg, O. G., Ilbäck, C., Sandegren, L., Hughes, D., & Andersson, D. I. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002158 · Cited by 1,654
Distinguishing between resistance, tolerance and persistence to antibiotic treatment
Brauner, A., Fridman, O., Gefen, O., & Balaban, N. Q. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.34 · Cited by 1,612
SOS response promotes horizontal dissemination of antibiotic resistance genes
Beaber, J. W., Hochhut, B., & Waldor, M. K. (2004) · Nature · doi:10.1038/nature02241 · Cited by 1,186
Sublethal Antibiotic Treatment Leads to Multidrug Resistance via Radical-Induced Mutagenesis
Kohanski, M. A., DePristo, M. A., & Collins, J. J. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.01.003 · Cited by 985
Commensal bacteria at the interface of host metabolism and the immune system
Brestoff, J. R., & Artis, D. (2013) · Nature Immunology · doi:10.1038/ni.2640 · Cited by 945
Antibiotics and the Human Gut Microbiome: Dysbioses and Accumulation of Resistances
Francino, M. P. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.01543 · Cited by 945
Antibiotic-Induced Changes in the Intestinal Microbiota and Disease
Becattini, S., Taur, Y., & Pamer, E. G. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.04.003 · Cited by 901
The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery
Smith, D. A., Di, L., & Kerns, E. H. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3287 · Cited by 898
Ciprofloxacin Causes Persister Formation by Inducing the TisB toxin in Escherichia coli
Dörr, T., Vulić, M., & Lewis, K. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000317 · Cited by 782
Sequencing and beyond: integrating molecular 'omics' for microbial community profiling
Franzosa, E. A., Hsu, T., Sirota-Madi, A., Shafquat, A., Abu-Ali, G., Morgan, X. C., & Huttenhower, C. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3451 · Cited by 719
Intestinal microbiome is related to lifetime antibiotic use in Finnish pre-school children
Korpela, K., Salonen, A., Virta, L. J., Kekkonen, R. A., Forslund, K., Bork, P., & de Vos, W. M. (2016) · Nature Communications · doi:10.1038/ncomms10410 · Cited by 698
Bacterial charity work leads to population-wide resistance
Lee, H. H., Molla, M. N., Cantor, C. R., & Collins, J. J. (2010) · Nature · doi:10.1038/nature09354 · Cited by 638
Antibiotic alternatives: the substitution of antibiotics in animal husbandry?
Cheng, G., Hao, H., Xie, S., Wang, X., Dai, M., Huang, L., & Yuan, Z. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00217 · Cited by 622
Self-citationOptimization of lag time underlies antibiotic tolerance in evolved bacterial populations
Fridman, O., Goldberg, A., Ronin, I., Shoresh, N., & Balaban, N. Q. (2014) · Nature · doi:10.1038/nature13469 · Cited by 613
Setting and Revising Antibacterial Susceptibility Breakpoints
Turnidge, J., & Paterson, D. L. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00047-06 · Cited by 578
Drug Tolerance in Replicating Mycobacteria Mediated by a Macrophage-Induced Efflux Mechanism
Adams, K. N., Takaki, K., Connolly, L. E., Wiedenhoft, H., Winglee, K., Humbert, O., Edelstein, P. H., Cosma, C. L., & Ramakrishnan, L. (2011) · Cell · doi:10.1016/j.cell.2011.02.022 · Cited by 530
Antibiotics as signalling molecules
Yim, G., Huimi Wang, H., & Davies FRS, J. (2007) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2007.2044 · Cited by 495
Guidelines for the management of adult lower respiratory tract infections - Summary
Woodhead, M., Blasi, F., Ewig, S., Garau, J., Huchon, G., Ieven, M., Ortqvist, A., Schaberg, T., Torres, A., van der Heijden, G., et al. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03602.x · Cited by 468
Microbial Persistence and the Road to Drug Resistance
Cohen, N. R., Lobritz, M. A., & Collins, J. J. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.05.009 · Cited by 460
Developmental dynamics of the preterm infant gut microbiota and antibiotic resistome
Gibson, M. K., Wang, B., Ahmadi, S., Burnham, C.-A. D., Tarr, P. I., Warner, B. B., & Dantas, G. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.24 · Cited by 457
Redox-Active Antibiotics Control Gene Expression and Community Behavior in Divergent Bacteria
Dietrich, L. E. P., Teal, T. K., Price-Whelan, A., & Newman, D. K. (2008) · Science · doi:10.1126/science.1160619 · Cited by 449
The mutant selection window and antimicrobial resistance
Drlica, K. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg269 · Cited by 437
Antibiotics as Signal Molecules
Romero, D., Traxler, M. F., López, D., & Kolter, R. (2011) · Chemical Reviews · doi:10.1021/cr2000509 · Cited by 390
Mutant Selection Window Hypothesis Updated
Drlica, K., & Zhao, X. (2007) · Clinical Infectious Diseases · doi:10.1086/511642 · Cited by 383
Gutierrez, A., Laureti, L., Crussard, S., Abida, H., Rodríguez-Rojas, A., Blázquez, J., Baharoglu, Z., Mazel, D., Darfeuille, F., Vogel, J., et al. (2013) · Nature Communications · doi:10.1038/ncomms2607 · Cited by 373
Metabolic Control of Persister Formation in Escherichia coli
Amato, S. M., Orman, M. A., & Brynildsen, M. P. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.04.002 · Cited by 370
Antibiotic Discovery: Combatting Bacterial Resistance in Cells and in Biofilm Communities
Penesyan, A., Gillings, M., & Paulsen, I. (2015) · Molecules · doi:10.3390/molecules20045286 · Cited by 363
Towards diagnostic guidelines for biofilm-associated infections
Hall-Stoodley, L., Stoodley, P., Kathju, S., Høiby, N., Moser, C., William Costerton, J., Moter, A., & Bjarnsholt, T. (2012) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2012.00968.x · Cited by 357
Antibiotics, microbiota, and immune defense
Ubeda, C., & Pamer, E. G. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.05.003 · Cited by 356
Antibiotics as signals that trigger specific bacterial responses
Fajardo, A., & Martínez, J. L. (2008) · Current Opinion in Microbiology · doi:10.1016/j.mib.2008.02.006 · Cited by 340
Young, V. B., & Schmidt, T. M. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.3.1203-1206.2004 · Cited by 335
Modulation of immune development and function by intestinal microbiota
Kabat, A. M., Srinivasan, N., & Maloy, K. J. (2014) · Trends in Immunology · doi:10.1016/j.it.2014.07.010 · Cited by 314
Úbeda, C., Maiques, E., Knecht, E., Lasa, Í., Novick, R. P., & Penadés, J. R. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.04584.x · Cited by 311
Dynamics of intracellular bacterial replication at the single cell level
Helaine, S., Thompson, J. A., Watson, K. G., Liu, M., Boyle, C., & Holden, D. W. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000041107 · Cited by 308
Manina, G., Dhar, N., & McKinney, J. D. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2014.11.016 · Cited by 300
Stryjewski, M. E., Graham, D. R., Wilson, S. E., O’Riordan, W., Young, D., Lentnek, A., Ross, D. P., Fowler, V. G., Hopkins, A., Friedland, H. D., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/587896 · Cited by 289
Mascio, C. T. M., Alder, J. D., & Silverman, J. A. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00824-07 · Cited by 276
Bernier, S. P., Lebeaux, D., DeFrancesco, A. S., Valomon, A., Soubigou, G., Coppée, J.-Y., Ghigo, J.-M., & Beloin, C. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003144 · Cited by 262
Functional relationship between bacterial cell density and the efficacy of antibiotics
Udekwu, K. I., Parrish, N., Ankomah, P., Baquero, F., & Levin, B. R. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn554 · Cited by 250
Protein Binding: Do We Ever Learn?
Zeitlinger, M. A., Derendorf, H., Mouton, J. W., Cars, O., Craig, W. A., Andes, D., & Theuretzbacher, U. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01433-10 · Cited by 249
Brook, I. (1989) · Clinical Infectious Diseases · doi:10.1093/clinids/11.3.361 · Cited by 241
Baharoglu, Z., & Mazel, D. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01549-10 · Cited by 240
Antibiotic‐Selective Environments
Baquero, F., Negri, M., Morosini, M., & Blázquez, J. (1998) · Clinical Infectious Diseases · doi:10.1086/514916 · Cited by 237
Early Development of the Gut Microbiota and Immune Health
Francino, M. (2014) · Pathogens · doi:10.3390/pathogens3030769 · Cited by 207
Immunomodulatory Activities of Fluoroquinolones
Dalhoff, A. (2005) · Infection · doi:10.1007/s15010-005-8209-8 · Cited by 203
Persisters and beyond: Mechanisms of phenotypic drug resistance and drug tolerance in bacteria
Kester, J. C., & Fortune, S. M. (2014) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2013.869543 · Cited by 202
Mouton, J. W., Ambrose, P. G., Canton, R., Drusano, G. L., Harbarth, S., MacGowan, A., Theuretzbacher, U., & Turnidge, J. (2011) · Drug Resistance Updates · doi:10.1016/j.drup.2011.02.005 · Cited by 200
Low-level antibacterial resistance: a gateway to clinical resistance
Baquero, F. (2001) · Drug Resistance Updates · doi:10.1054/drup.2001.0196 · Cited by 193
Pharmacodynamics, Population Dynamics, and the Evolution of Persistence in Staphylococcus aureus
Johnson, P. J. T., & Levin, B. R. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003123 · Cited by 190
Host-mediated sugar oxidation promotes post-antibiotic pathogen expansion
Faber, F., Tran, L., Byndloss, M. X., Lopez, C. A., Velazquez, E. M., Kerrinnes, T., Nuccio, S.-P., Wangdi, T., Fiehn, O., Tsolis, R. M., et al. (2016) · Nature · doi:10.1038/nature18597 · Cited by 180
Thi, T. D., Lopez, E., Rodriguez-Rojas, A., Rodriguez-Beltran, J., Couce, A., Guelfo, J. R., Castaneda-Garcia, A., & Blazquez, J. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq496 · Cited by 167
Antimicrobial Drugs in Fighting against Antimicrobial Resistance
Cheng, G., Dai, M., Ahmed, S., Hao, H., Wang, X., & Yuan, Z. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00470 · Cited by 165
Self-citationBiofilm Formation by Helicobacter pylori and Its Involvement for Antibiotic Resistance
Yonezawa, H., Osaki, T., & Kamiya, S. (2015) · BioMed Research International · doi:10.1155/2015/914791 · Cited by 164
Role of the microbiome, probiotics, and ‘dysbiosis therapy’ in critical illness
Wischmeyer, P. E., McDonald, D., & Knight, R. (2016) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000321 · Cited by 159
Liu, A., Fong, A., Becket, E., Yuan, J., Tamae, C., Medrano, L., Maiz, M., Wahba, C., Lee, C., Lee, K., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01182-10 · Cited by 151
Bulitta, J. B., Yang, J. C., Yohonn, L., Ly, N. S., Brown, S. V., D'Hondt, R. E., Jusko, W. J., Forrest, A., & Tsuji, B. T. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00881-09 · Cited by 144
López‐Camacho, E., Elez, M., Matić, I., & Blázquez, J. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05642.x · Cited by 143
Adams, K. N., Szumowski, J. D., & Ramakrishnan, L. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu095 · Cited by 141
Pharmacodynamics of Telavancin (TD-6424), a Novel Bactericidal Agent, against Gram-Positive Bacteria
Hegde, S. S., Reyes, N., Wiens, T., Vanasse, N., Skinner, R., McCullough, J. L., Kaniga, K., Pace, J., Thomas, R., Shaw, J., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.8.3043-3050.2004 · Cited by 134
Antibiotic perturbation of the preterm infant gut microbiome and resistome
Gasparrini, A. J., Crofts, T. S., Gibson, M. K., Tarr, P. I., Warner, B. B., & Dantas, G. A. (2016) · Gut Microbes · doi:10.1080/19490976.2016.1218584 · Cited by 134
Effect of protein binding of daptomycin on MIC and antibacterial activity
Lee, B. L., Sachdeva, M., & Chambers, H. F. “. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.12.2505 · Cited by 133
The habitat, double life, citizenship, and forgetfulness of IgA
Macpherson, A. J., Geuking, M. B., Slack, E. M. C., Hapfelmeier, S., & McCoy, K. D. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01072.x · Cited by 131
Large mutational target size for rapid emergence of bacterial persistence
Girgis, H. S., Harris, K. K., & Tavazoie, S. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205124109 · Cited by 129
Ghosh, T. S., Gupta, S. S., Nair, G. B., & Mande, S. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083823 · Cited by 109
Kim, J., Heo, P., Yang, T.-J., Lee, K.-S., Cho, D.-H., Kim, B., Suh, J.-H., Lim, H., Shin, D., Kim, S.-K., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00708-11 · Cited by 108
López‐Camacho, E., & Blázquez, J. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00358-09 · Cited by 103
Promoter activity dynamics in the lag phase of Escherichia coli
Madar, D., Dekel, E., Bren, A., Zimmer, A., Porat, Z., & Alon, U. S. (2013) · BMC Systems Biology · doi:10.1186/1752-0509-7-136 · Cited by 98
Bae, J., Oh, E., & Jeon, B. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04066-14 · Cited by 96
Veterinary Medicine Needs New Green Antimicrobial Drugs
Toutain, P., Ferran, A. A., Bousquet‐mélou, A., Pelligand, L., & Lees, P. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01196 · Cited by 83
Mizunaga, S., Kamiyama, T., Fukuda, Y., Takahata, M., & Mitsuyama, J. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki163 · Cited by 78
Beer, J., Wagner, C. C., & Zeitlinger, M. A. (2009) · The AAPS Journal · doi:10.1208/s12248-008-9072-1 · Cited by 74
Chambers, H. F. “., Mills, J. L., Drake, T. A., & Sande, M. A. (1984) · Clinical Infectious Diseases · doi:10.1093/clinids/6.supplement_4.s870 · Cited by 73
Docobo-Pérez, F., López‐Cerero, L., López-Rojas, R., Egea, P., Domínguez-Herrera, J., Rodríguez‐Baño, J., Pascual, Á., & Pachón, J. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02190-12 · Cited by 67
Lam, Y. W., Duroux, M. H., Gambertoglio, J. G., Barriere, S. L., & Guglielmo, B. J. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.3.298 · Cited by 66
Entenza, J. M., Giddey, M., Vouillamoz, J., & Moreillon, P. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.12.022 · Cited by 60
Intestinal microbiota composition after antibiotic treatment in early life: the INCA study
Rutten, N. B. M. M., Rijkers, G. T., Meijssen, C. B., Crijns, C. E., Oudshoorn, J. H., van der Ent, C. K., & Vlieger, A. M. (2015) · BMC Pediatrics · doi:10.1186/s12887-015-0519-0 · Cited by 55
Jones, R. N., & Barry, A. L. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.5.818 · Cited by 51
Tyerman, J., Ponciano, J. M., Joyce, P., Forney, L. J., & Harmon, L. J. (2013) · BMC Evolutionary Biology · doi:10.1186/1471-2148-13-22 · Cited by 50
Influence of Human Serum on Antifungal Pharmacodynamics with Candida albicans
Zhanel, G. G., Saunders, D. G., Hoban, D. J., & Karlowsky, J. A. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.7.2018-2022.2001 · Cited by 47
Pharmacokinetics and pharmacodynamics of antimicrobial drugs
Czock, D., Markert, C., Hartmann, B., & Keller, F. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250902913808 · Cited by 40
Review of Pharmacokinetics and Pharmacodynamics of Antimicrobial Agents
Estes, L. L. (1998) · Mayo Clinic Proceedings · doi:10.4065/73.11.1114 · Cited by 38
Vasseur, M. V., Laurentie, M., Rolland, J.-G., Perrin‐Guyomard, A., Henri, J., Ferran, A. A., Toutain, P., & Bousquet‐mélou, A. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02135-13 · Cited by 37
Kaplan, N., Awrey, D. E., Bardouniotis, E., Berman, J., Yethon, J. A., Pauls, H. W., & Hafkin, B. (2013) · Journal of Chemotherapy · doi:10.1179/1973947812y.0000000063 · Cited by 36
A Screen for and Validation of Prodrug Antimicrobials
Fleck, L. E., North, E. J., Lee, R. E., Jr., Mulcahy, L. R., Casadei, G., & Lewis, K. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02136-13 · Cited by 31
Nonspecific Effect of Mycograb on Amphotericin B MIC
Richie, D. L., Ghannoum, M. A., Isham, N. C., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00435-12 · Cited by 29
Human serum binding and its effect on the pharmacodynamics of the lantibiotic MU1140
Ghobrial, O. G., Derendorf, H., & Hillman, J. D. (2010) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2010.09.005 · Cited by 25
Rio, L. M., Hartke, A., & Bizzini, A. (2014) · Microbial Drug Resistance · doi:10.1089/mdr.2014.0059 · Cited by 22
Field, W., & Hershberg, R. (2015) · Genome Biology and Evolution · doi:10.1093/gbe/evv102 · Cited by 19
Antimicrobial Pharmacokinetics and Pharmacodynamics
Jarrell, A. S., Kruer, R. M., Johnson, D., & Lipsett, P. A. (2015) · Surgical Infections · doi:10.1089/sur.2014.180 · Cited by 16
Antibiotics, gut bugs and the young
Browne, H. P. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.73 · Cited by 11
Ferran, A. A., Toutain, P., & Bousquet‐mélou, A. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.07.007 · Cited by 4
Cited by
The Minimum Inhibitory Concentration of Antibiotics: Methods, Interpretation, Clinical Relevance
Kowalska-Krochmal, B., & Dudek-Wicher, R. (2021) · Pathogens · doi:10.3390/pathogens10020165 · Cited by 1,039
Dawan, J., Wei, S., & Ahn, J. (2020) · Annals of Microbiology · doi:10.1186/s13213-020-01552-1 · Cited by 30
Metadata
- Authors
- Li, J., Xie, S., Ahmed, S., Wang, F., Gu, Y., Zhang, C., Chai, X., Wu, Y., Cai, J., & Cheng, G.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2017-06-13
- Volume
- 8
- Pages
- 364-364
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W2625713836
- Cited by
- 266
- References
- 98
- FWCI
- 9.73
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.